Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 84

Sort by

Sort Order Select

Journal Articles

Two-Year Updated Results of Asciminib Managed-Access Program (MAP) in Russia

Anna Turkina, Elena A. Kuzmina, Elza Lomaia, Elena Morozova, Oleg A. Shukhov, Anna N. Petrova, Tamara Chitanava, Julia J. Vlasova, Ekaterina Yu. Chelysheva, Evgeniya Sbityakova, Irina S. Nemchenko, Anastasiya V. Bykova, Margarita A. Gurianova, Alina V. Kokhno, Elena N. Parovichnikova

Blood (2022) 140 (Supplement 1): 9654–9655.

https://doi.org/10.1182/blood-2022-162268

Published: 2022

Journal Articles

Long-Term Outcome of Second Allogeneic Stem Cell Transplantation (HSCT2) for Primary Graft Failure in Patients with Acute Leukemia in Remission: A Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Arnon Nagler, Myriam Labopin, Alexander D. Kulagin, Andrea Velardi, Jaime Sanz, Hélène Labussière-Wallet, Victoria Potter, Jurgen Kuball, Simona Sica, Elena N. Parovichnikova, Wolfgang Bethge, Xavier Leleu, Uwe Platzbecker, Friedrich Stölzel, Fabio Ciceri, Mohamad Mohty

Blood (2022) 140 (Supplement 1): 7578–7579.

https://doi.org/10.1182/blood-2022-156231

Published: 2022

Journal Articles

Non-Intensive Continuous Treatment with a Tyrosine Kinase Inhibitor (TKI) Followed By Allo-HSCT Is an Effective Therapeutic Strategy for Adult Ph-Positive Acute Lymphoblastic Leukemia: Outcomes of the Russian Prospective Multicenter RALL Study

Olga A. Gavrilina, Elena N. Parovichnikova, Vera V. Troitskaya, Zalina Kh. Akhmerzaeva, Sergey N. Bondarenko, Valery A. Lapin, Maria E. Grishunina, Olga S. Samoylova, Tatiana S. Konstantinova, Larisa A. Kuzmina, Julia A. Chabaeva, Valery G. Savchenko

Blood (2021) 138 (Supplement 1): 4395.

https://doi.org/10.1182/blood-2021-153068

Published: 2021

Journal Articles

Dynamics of Cytokines Concentration in the Blood Plasma of Patients after Multipotent Mesenchymal Stromal Cells Administration for Graft Versus Host Disease Prevention

Nataliya A. Petinati, Julia O Davydova, Kseniya A. Nikiforova, Alexey Bigildeev, Georgiy Arapidi, Nina J. Drize, Larisa A. Kuzmina, Elena N. Parovichnikova, Valeriy G. Savchenko

Blood (2021) 138 (Supplement 1): 1101.

https://doi.org/10.1182/blood-2021-144552

Published: 2021

Journal Articles

Outcomes in Patients with Hematologic Disease and COVID-19 in Russia: Interim Analysis of CHRONOS19 Registry

Blood (2020) 136 (Supplement 1): 41–42.

https://doi.org/10.1182/blood-2020-138504

Published: 2020

Journal Articles

The Role of Genetic Polymorphisms of TPMT and NUDT15 Genes in Adult Patients with Ph-Negative Acute Lymphoblastic Leukemia in Russia

Ekaterina S. Kotova, Olga A. Gavrilina, MDPhD, Igor A Yakutik, PhD, Andrey B. Sudarikov, PhD DSc, Elena N. Parovichnikova, MD PhD, Vera V. Troitskaya, MD PhD, Andrey N. Sokolov, MD PhD, Galina A. Isinova, MD PhD, Ksenija I. Zarubina, MD, Valeriy G. Savchenko, MD PhD

Blood (2020) 136 (Supplement 1): 21–22.

https://doi.org/10.1182/blood-2020-141804

Published: 2020

Journal Articles

Clinical Exome Sequencing in B-Cell Ph-Negative ALL Patient Demonstrates Clonal Changes at Different Stages of the Disease

Kseniia I. Zarubina, Elena N. Parovichnikova, MD PhD, Vadim L. Surin, Olesya S. Pshenichnikova, PhD, Ekaterina Y. Demidova, PhD, Bella V. Biderman, PhD, Andrey B. Sudarikov, PhD DSc, Galina A. Baskhaeva, MD PhD, Olga A. Gavrilina, MDPhD, Ekaterina S. Kotova, Andrey N. Sokolov, MD PhD, Vera V. Troitskaya, MD PhD, Valeriy G. Savchenko, MD PhD

Blood (2020) 136 (Supplement 1): 9–10.

https://doi.org/10.1182/blood-2020-136041

Published: 2020

Journal Articles

Serum Albumin Level, but Not Nutritional Risk Index Predicts Outcomes in Acute Leukemia Patients after Allo-HSCT

Mikhail Yu. Drokov, MD PhD, Natalia N. Popova, MD, Vera A. Vasilyeva, MD PhD, Ekaterina D. Mikhaltsova, MD PhD, Olga M. Koroleva, MD, Zoya V. Konova, Anna A. Dmitrova, MD, Olga S. Starikova, MD, Ulyana V. Maslikova, MD, Maria V. Dovydenko, MD PhD, Ekterina Usikova, Larisa A. Kuzmina, MD PhD, Elena N. Parovichnikova, MD PhD, Valery G. Savchenko, MD PhD academician

Blood (2019) 134 (Supplement_1): 1987.

https://doi.org/10.1182/blood-2019-126822

Published: 2019

Journal Articles

Impact of Minimal Residual Disease Detected By Multiparameter Flow Cytometry on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia Patients in First Complete Remission

Zoya V. Konova, Elena N. Parovichnikova, MD PhD, Irina V. Galtseva, MD PhD, Nikolay M. Kapranov, Julia O. Davydova, Mikhail Yu. Drokov, MD PhD, Maria V. Nareyko, MD, Natalia N. Popova, MD, Anna A. Dmitrova, MD, Ulyana V. Maslikova, MD, Olga S. Starikova, MD, Ekaterina I. Usikova, MD, Ekaterina D. Mikhaltsova, MD PhD, Olga M. Koroleva, MD, Vera A. Vasilyeva, MD PhD, Tatiana I. Lobanova, MD, Larisa A. Kuzmina, MD PhD, Valeriy G. Savchenko, MD PhD

Blood (2019) 134 (Supplement_1): 4562.

https://doi.org/10.1182/blood-2019-123528

Published: 2019

Journal Articles

The Choice of Treatment for Elderly AML-Patients: 7+3 or Low Doses ARA-C

Vera V. Troitskaya, MD PhD, Elena N. Parovichnikova, MD PhD, Andrey N. Sokolov, MD PhD, Alina V. Kokhno, MD PhD, Zalina T. Fidarova, MD PhD, Olga A. Gavrilina, MD PhD, Tatiana I. Lobanova, MD, Elena O. Gribanova, MD PhD, Sergey K. Kravchenko, MD PhD, Gennadiy M. Galstyan, MD PhD, Sergei M. Kulikov, PhD, Julia A. Chabaeva, Valeriy G. Savchenko, MD PhD

Blood (2019) 134 (Supplement_1): 5136.

https://doi.org/10.1182/blood-2019-124056

Published: 2019

Journal Articles

Primary Antigen Aberrations and Immunophenotype Shifts of Blasts in AML Patients during the Treatment and at the Time of Relapse

Tatiana I. Lobanova, MD, Elena N. Parovichnikova, MD PhD, Irina V. Galtseva, MD PhD, Vera V. Troitskaya, MD PhD, Julia O. Davydova, Nikolay M. Kapranov, Andrey N. Sokolov, MD PhD, Sergei M. Kulikov, PhD, Valery G. Savchenko, MD PhD academician

Blood (2019) 134 (Supplement_1): 5183.

https://doi.org/10.1182/blood-2019-128650

Published: 2019

Journal Articles

Changes in the Multipotent Stromal Mesenchymal Cells from the Bone Marrow of the Patients with Hematological Diseases in Debut and after the Treatment

Irina N. Shipounova, PhD, Nataliya A. Petinati, MD PhD, Nina J. Drize, PhD, Aminat A. Magomedova, MD PhD, Ekaterina A. Fastova, MD, Sergey K. Kravchenko, MD PhD, Ekaterina Yu. Chelysheva, MD PhD, Oleg A. Shukhov, MD PhD, Anna G. Turkina, Prof., MD, Elena N. Parovichnikova, MD PhD, Valery G. Savchenko, MD PhD academician

Blood (2019) 134 (Supplement_1): 5014.

https://doi.org/10.1182/blood-2019-123396

Published: 2019

Journal Articles

Interim Results of Russian Acute Lymphoblastic Leukemia (RALL-2016) Study with Centralized MRD-Monitoring and Randomization for Autologous HSCT with Non-Myeloablative Conditioning in Adult Ph-Negative ALL Patients

Blood (2019) 134 (Supplement_1): 5072.

https://doi.org/10.1182/blood-2019-124701

Published: 2019

Journal Articles

Loss of Heterozygosity in the Short Tandem Repeat (STR) Loci Found in Tumor DNA of De Novo Diagnosed ALL Patients As a Factor Predicting Poor Outcome

Natalya V Risinskaya, PhD, Olga A. Gavrilina, MD PhD, Julia A. Chabaeva, Anna Yushkova, Andrey B Sudarikov, PhD DSc, Sergei M. Kulikov, PhD, Elena N. Parovichnikova, MD PhD, Valery G. Savchenko, MD PhD academician

Blood (2019) 134 (Supplement_1): 5204.

https://doi.org/10.1182/blood-2019-126668

Published: 2019

Journal Articles

Haploidentical Stem Cell Transplantation with TCR Alpha/Beta and CD19 Depletion in Adult Patients with Hematological Malignancies

Maria V. Dovydenko, MD PhD, Elena N. Parovichnikova, MD PhD, Larisa A. Kuzmina, MD PhD, Vera A. Vasilyeva, MD PhD, Mikhail Yu. Drokov, MD PhD, Olga M. Koroleva, MD, Ekaterina D. Mikhaltsova, MD PhD, Natalia N. Popova, MD, Zoya V. Konova, Anna A. Dmitrova, MD, Ulyana V. Maslikova, MD, Olga S. Starikova, MD, Tatiana V. Gaponova, MD PhD, Denis V. Kamelskih, MD, Michael Maschan, MDMSc, Valeriy G. Savchenko, MD PhD

Blood (2019) 134 (Supplement_1): 5648.

https://doi.org/10.1182/blood-2019-131316

Published: 2019

Journal Articles

Oligoclonal Expansion and T-Cells Subpopulations in Patients with Aplastic Anemia at Different Stages of the Disease

Anastasia V. Abramova, MD, Elena A. Mikhaylova, MD PhD Prof, Zalina T. Fidarova, MD PhD, Yuliya O. Davydova, Nikolay M. Kapranov, Tatiana I. Lobanova, MD, Anton V. Luchkin, MD, Alina E. Krasilnikova, Resident Physician, Roman V. Tivikov, MD, Vera V. Troitskaya, MD PhD, Irina V. Galtseva, PhD, Elena N. Parovichnikova, MD PhD, Valery G. Savchenko, MD PhD academician

Blood (2018) 132 (Supplement 1): 3864.

https://doi.org/10.1182/blood-2018-99-119414

Published: 2018

Journal Articles

MRD Status Did Not Correspond to the Relapse Incidence within One Year of Follow-up By Non-Intensive but Non-Interruptive Approach: The First Interim Results of the Russian Prospective Multicenter RALL-2016 Trial for Ph-Negative Adult ALL

Blood (2018) 132 (Supplement 1): 5185.

https://doi.org/10.1182/blood-2018-99-116318

Published: 2018

Journal Articles

The Effectiveness of Eltrombopag at the Different Stages of Aplastic Anemia and Probability of Clonal Expansion

Anton V. Luchkin, MD, Elena A. Mikhaylova, MD PhDProf, Zalina T. Fidarova, MD PhD, Anastasia V. Abramova, MD, Vera V. Troitskaya, MD PhD, Tatiana I. Lobanova, MD, Alina E. Krasilnikova, Resident Physician, Irina V. Galtseva, PhD, Yuliya O. Davydova, Nikolay M. Kapranov, Tatiana N. Obukhova, MD PhD, Lubov Grebenyuk, MD, Murat Vagida, MD, Elena N. Parovichnikova, MD PhD, Valery G. Savchenko, MD PhD academician

Blood (2018) 132 (Supplement 1): 5108.

https://doi.org/10.1182/blood-2018-99-118738

Published: 2018

Journal Articles

Long-Term Outcomes of De Novo Acute Myeloid Leukemia (AML) Patients (pts) with Life Threating Complications

Aleksei Bazhenov, MD, Elena N. Parovichnikova, MD PhD, Gennadiy M. Galstyan, MD PhD, Vera V. Troitskaya, MD PhD, Elena O. Gribanova, Valery G. Savchenko, MD PhD academician

Blood (2018) 132 (Supplement 1): 5898.

https://doi.org/10.1182/blood-2018-99-116114

Published: 2018

Journal Articles

Social Parameters Are Independent Predictors for Survival in Chronic Myeloid Leukemia

Sergei M. Kulikov, PhD, Anna G Turkina, Prof., MD, Anton Kulikovsky, Olga Lazareva, PhD, Sergey Kutsev, Prof., MD, PhD, Elza Lomaia, MD, Andrey Zaritskey, MD PhD, Anatoly Golenkov, MDProf, Tatiana Pospelova, MD PhD, Satokhin Yuri, MD PhD, Tatiana Konstantinova, MD PhD, Elena N. Parovichnikova, MD PhD, Valeriy G. Savchenko, MD PhD

Blood (2018) 132 (Supplement 1): 1735.

https://doi.org/10.1182/blood-2018-99-114700

Published: 2018

NARROW

Two-Year Updated Results of Asciminib Managed-Access Program (MAP) in Russia

Long-Term Outcome of Second Allogeneic Stem Cell Transplantation (HSCT2) for Primary Graft Failure in Patients with Acute Leukemia in Remission: A Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Non-Intensive Continuous Treatment with a Tyrosine Kinase Inhibitor (TKI) Followed By Allo-HSCT Is an Effective Therapeutic Strategy for Adult Ph-Positive Acute Lymphoblastic Leukemia: Outcomes of the Russian Prospective Multicenter RALL Study

Dynamics of Cytokines Concentration in the Blood Plasma of Patients after Multipotent Mesenchymal Stromal Cells Administration for Graft Versus Host Disease Prevention

Outcomes in Patients with Hematologic Disease and COVID-19 in Russia: Interim Analysis of CHRONOS19 Registry

The Role of Genetic Polymorphisms of TPMT and NUDT15 Genes in Adult Patients with Ph-Negative Acute Lymphoblastic Leukemia in Russia

Clinical Exome Sequencing in B-Cell Ph-Negative ALL Patient Demonstrates Clonal Changes at Different Stages of the Disease

Serum Albumin Level, but Not Nutritional Risk Index Predicts Outcomes in Acute Leukemia Patients after Allo-HSCT

Impact of Minimal Residual Disease Detected By Multiparameter Flow Cytometry on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia Patients in First Complete Remission

The Choice of Treatment for Elderly AML-Patients: 7+3 or Low Doses ARA-C

Primary Antigen Aberrations and Immunophenotype Shifts of Blasts in AML Patients during the Treatment and at the Time of Relapse

Changes in the Multipotent Stromal Mesenchymal Cells from the Bone Marrow of the Patients with Hematological Diseases in Debut and after the Treatment

Interim Results of Russian Acute Lymphoblastic Leukemia (RALL-2016) Study with Centralized MRD-Monitoring and Randomization for Autologous HSCT with Non-Myeloablative Conditioning in Adult Ph-Negative ALL Patients

Loss of Heterozygosity in the Short Tandem Repeat (STR) Loci Found in Tumor DNA of De Novo Diagnosed ALL Patients As a Factor Predicting Poor Outcome

Haploidentical Stem Cell Transplantation with TCR Alpha/Beta and CD19 Depletion in Adult Patients with Hematological Malignancies

Oligoclonal Expansion and T-Cells Subpopulations in Patients with Aplastic Anemia at Different Stages of the Disease

MRD Status Did Not Correspond to the Relapse Incidence within One Year of Follow-up By Non-Intensive but Non-Interruptive Approach: The First Interim Results of the Russian Prospective Multicenter RALL-2016 Trial for Ph-Negative Adult ALL

The Effectiveness of Eltrombopag at the Different Stages of Aplastic Anemia and Probability of Clonal Expansion

Long-Term Outcomes of De Novo Acute Myeloid Leukemia (AML) Patients (pts) with Life Threating Complications

Social Parameters Are Independent Predictors for Survival in Chronic Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only